Clinical trials have demonstrated reductions in HbA1c (a measure of average blood glucose over three months) with semaglutide treatment, with improvements varying based on baseline levels and dose
However, when it comes to weight loss, studies are mixed, with some showing success and others showing no difference [16] [17] [18]
References de Souto Barreto P, Rolland Y
In conclusion, vitamin B12 deficiency is a common health issue that can have severe negative effects on our bodies
Insightful as always, Brittany!
(Wegovy, Mounjaro & the New Pill, 2026) Updated 22/06/26 Based on the available clinical evidence, Mounjaro (tirzepatide) and Wegovy (semaglutide) are both well tolerated, but most people find Mounjaro causes fewer gastrointestinal side effects at comparable doses, with lower rates of nausea and a higher likelihood of completing treatment